Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
5.54
-0.21 (-3.61%)
May 9, 2025, 9:53 AM - Market open
Serina Therapeutics Revenue
Serina Therapeutics had revenue of $51.00K in the twelve months ending March 31, 2025, down -98.37% year-over-year. In the year 2024, Serina Therapeutics had annual revenue of $56.00K, down -98.22%.
Revenue (ttm)
$51.00K
Revenue Growth
-98.37%
P/S Ratio
1,118.89
Revenue / Employee
$3,923
Employees
13
Market Cap
55.00M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 56.00K | -3.10M | -98.22% |
Dec 31, 2023 | 3.15M | 2.56M | 433.05% |
Dec 31, 2022 | 591.50K | -2.87M | -82.93% |
Dec 31, 2021 | 3.46M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSER News
- 10 days ago - Serina Therapeutics to Present at JonesResearch Virtual CNS Day - GlobeNewsWire
- 24 days ago - Serina Therapeutics to Present at the 4th LNP Formulation & Process Development Summit - GlobeNewsWire
- 4 weeks ago - Serina Therapeutics Secures $5 Million in Funding to Support Advancement of SER-252 into Clinical Development in Advanced Parkinson's Disease - GlobeNewsWire
- 4 weeks ago - Serina Therapeutics to Present at the Jones Healthcare and Technology Innovation Conference - GlobeNewsWire
- 6 weeks ago - Serina Therapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 6 weeks ago - Serina Therapeutics to Present at the American Chemistry Society (ACS) Spring 2025 Meeting - GlobeNewsWire
- 3 months ago - Serina Therapeutics Appoints Dr. Jay Venkatesan to its Board of Directors - GlobeNewsWire
- 3 months ago - Serina Therapeutics Receives Second $5 Million Tranche to Strengthen Cash Position Ahead of Phase 1 Clinical Trial in Advanced Parkinson's Disease Patients - GlobeNewsWire